Outpatient Treatment Services 9594CS26Q0003

This is a pre-solicitation notice for 9594CS26Q0003, Outpatient Treatment Services at the Court Services and Offender Supervision Agency (CSOSA) in Washington, DC. The requirement is for evidence-based outpatient or early intervention substance use disorder (SUD) treatment services to CSOSA offenders based upon an assessed level of care or a court order for treatment. The forthcoming solicitation will be advertised as a total set-aside for small businesses under NAICS code 621420, Outpatient Mental Health and Substanc Abuse Centers. The resultant purchase order award is anticipated to be for one 12-month base period with four 12-month option periods. A solicitation is anticipated to be issued by February 10, 2026. The forthcoming solicitation will identify all requirements for submitting a response. CSOSA contemplates an award with firm-fixed unit prices and estimated quantities. No information other than that included in this presolicitation notice is available at this time.

This solicitation is for evidence-based outpatient or early intervention substance use treatment servics to CSOSA offenders based upon an assessed level of care or a court order for treatment. The solicitation is 100% set-aside for small business under NAICS 621420, Outpatient Mental Health and Substance Abuse Centers. The resultant award is anticipated to be for one 12-month base period and four 12-month option periods. The soicitation includes outpatient treatment services in accordance with American Society of Addiction Medicine (ASAM) criteria, Level 1.5, and early intervention services in accordance with ASAM criteria. Early intervention services are available under this acquisition only to offenders with a court mandate to participate in the Traffice and Alcohol Program (TAP). In addition to the above, this acquisition requires the Contractor to provide various translation services, when authorized, and requires the Contractor to maintain offender electronic treatment files to be be transferred to CSOSA upon completion of treatment services via CRISP (Chesapeake Regional Information System for our Patients). Submissions in response to this announcement must include all required information identified in solicitation section L.4.3 and L.4.4. Due dates for questions and submissions are identified in the solicitation section L.5 and L.6.

The attached Amendment 0001 provides responses to questions received regarding solicitation 9594CS26Q0003, Outpatient Treatment Services, make changes to the solicitation, and extends the due date for quotations. The revised Attachment J-15 included with this amendment must be used to submit any price quote in response to solicitation 9594CS26Q0003 as it reflects the correct quantities. This solicitation is for evidence-based outpatient or early intervention substance use treatment servics to CSOSA offenders based upon an assessed level of care or a court order for treatment. The solicitation is 100% set-aside for small business under NAICS 621420, Outpatient Mental Health and Substance Abuse Centers. The resultant award is anticipated to be for one 12-month base period and four 12-month option periods. The soicitation includes outpatient treatment services in accordance with American Society of Addiction Medicine (ASAM) criteria, Level 1.5, and early intervention services in accordance with ASAM criteria. Early intervention services are available under this acquisition only to offenders with a court mandate to participate in the Traffice and Alcohol Program (TAP). In addition to the above, this acquisition requires the Contractor to provide various translation services, when authorized, and requires the Contractor to maintain offender electronic treatment files to be be transferred to CSOSA upon completion of treatment services via CRISP (Chesapeake Regional Information System for our Patients). Submissions in response to this announcement must include all required information identified in solicitation section L.4.3 and L.4.4. Due dates for questions and submissions are identified in the solicitation section L.5 and L.6.

The attachment Amendment 0002 corrects some information in Amendment 0001, changes the solicitation from a small business set-aside to unrestricted (i.e., open to all business sizes), and extends the due date for quotations. The attached Amendment 0001 provides responses to questions received regarding solicitation 9594CS26Q0003, Outpatient Treatment Services, make changes to the solicitation, and extends the due date for quotations. The revised Attachment J-15 included with this amendment must be used to submit any price quote in response to solicitation 9594CS26Q0003 as it reflects the correct quantities. This solicitation is for evidence-based outpatient or early intervention substance use treatment servics to CSOSA offenders based upon an assessed level of care or a court order for treatment. The solicitation is 100% set-aside for small business under NAICS 621420, Outpatient Mental Health and Substance Abuse Centers. The resultant award is anticipated to be for one 12-month base period and four 12-month option periods. The soicitation includes outpatient treatment services in accordance with American Society of Addiction Medicine (ASAM) criteria, Level 1.5, and early intervention services in accordance with ASAM criteria. Early intervention services are available under this acquisition only to offenders with a court mandate to participate in the Traffice and Alcohol Program (TAP). In addition to the above, this acquisition requires the Contractor to provide various translation services, when authorized, and requires the Contractor to maintain offender electronic treatment files to be be transferred to CSOSA upon completion of treatment services via CRISP (Chesapeake Regional Information System for our Patients). Submissions in response to this announcement must include all required information identified in solicitation section L.4.3 and L.4.4. Due dates for questions and submissions are identified in the solicitation section L.5 and L.6.

The attached Amendment 0003 provides responses to additional questions received regarding solicitation 9594CS26Q0003, Outpatient Treatment Services. No changes are made to the solicitation as a result of these responses and there is no change to the due date and time for submission of quotations identified in Amendment 0002. The attachment Amendment 0002 corrects some information in Amendment 0001, changes the solicitation from a small business set-aside to unrestricted (i.e., open to all business sizes), and extends the due date for quotations. The attached Amendment 0001 provides responses to questions received regarding solicitation 9594CS26Q0003, Outpatient Treatment Services, make changes to the solicitation, and extends the due date for quotations. The revised Attachment J-15 included with this amendment must be used to submit any price quote in response to solicitation 9594CS26Q0003 as it reflects the correct quantities. This solicitation is for evidence-based outpatient or early intervention substance use treatment servics to CSOSA offenders based upon an assessed level of care or a court order for treatment. The solicitation is 100% set-aside for small business under NAICS 621420, Outpatient Mental Health and Substance Abuse Centers. The resultant award is anticipated to be for one 12-month base period and four 12-month option periods. The solicitation includes outpatient treatment services in accordance with American Society of Addiction Medicine (ASAM) criteria, Level 1.5, and early intervention services in accordance with ASAM criteria. Early intervention services are available under this acquisition only to offenders with a court mandate to participate in the Traffice and Alcohol Program (TAP). In addition to the above, this acquisition requires the Contractor to provide various translation services, when authorized, and requires the Contractor to maintain offender electronic treatment files to be be transferred to CSOSA upon completion of treatment services via CRISP (Chesapeake Regional Information System for our Patients). Submissions in response to this announcement must include all required information identified in solicitation section L.4.3 and L.4.4. Due dates for questions and submissions are identified in the solicitation section L.5 and L.6.